Caleb Rans

Contributing Writer https://www.oncologynurseadvisor.com

Caleb Rans is a clinical pharmacist and medical communications specialist with professional expertise in medical writing, editing, and contract clinical research. He holds a PharmD from the University of Alberta and presently resides in Vancouver, Canada. He currently works as an independent consultant for several news, CME, and pharmaceutical companies.

All articles by Caleb Rans

This fact sheet provides an overview of the updated ESMO clinical practice guideline for hereditary GI cancers.

Side-Effect Management

New ASCO Clinical Guidelines on Management of Cancer Cachexia

By

Caleb Rans

June 25, 2020

The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.

Current treatment strategies for immune thrombocytopenic purpura are centered on immunomodulation and decreasing platelet destruction

Improving the Clinical Diagnosis and Classification of Gray Zone Lymphomas

By

Caleb Rans

September 26, 2019

Although gray zone lymphoma has distinct morphologic features, immunophenotyping can make classifying gray zone lymphoma challenging.

Next post in Lymphoma

Researchers conducted a meta-analysis of studies evaluating survival outcomes with rituximab plus chemotherapy with or without autologous HSCT.

No Benefit With Upfront Rituximab and Autologous HSCT Consolidation for Aggressive Non-Hodgkin Lymphomas